Nanjing’s R&D cell inauguration Unither Pharmaceuticals: Innovation at the heart of R&D Article taken from a speech by Nathalie MASSON, Director of Innovation... View Article
What makes us proud? Éric Goupil, President of Unither Pharmaceuticals, shares his Vision of Pride at BPI France’s BIG Event Unither Pharmaceuticals, a... View Article
Anticipating Customer Growth A massive investment plan to increase our capacity and respond to CSR challenges Author: Eric Chesnel, Commercial & Licensing... View Article
World Sight Day World Sight Day aims to raise awareness and draw attention to blindness and visual impairment. As part of this... View Article
LDPE study Comparative Carbon Footprint Analysis of Regenerated LDPE vs. Virgin LDPE Low-Density Polyethylene (LDPE) is a plastic used for the production... View Article
Investing in production capacity Interview of Jean-François Hilaire by PHARMAnetwork magazine – N°58 ; P51 Creating a predictable framework that will allow pharmaceutical manufacturers... View Article
Unither Développement Bordeaux new Landing Page UDB: You innovation and development partner For over 30 years, UDB (Unither Développement Bordeaux) has developed pharmaceutical formulations to support... View Article
Foundation stone laid for Laboratoire Unither Amiens new building PRESS RELEASE Foundation stone laid for Laboratoire Unither Amiens new building As part of the Foundation Stone Laying Ceremony... View Article
Pharnext moves production of its pending drug PXT303 to the United States Published on 01/26/2023 (AOF) – Pharnext, a biotech company developing new treatments for neurodegenerative diseases without satisfactory therapeutic solutions, today... View Article
